Luisa Bortesi

Luisa Bortesi


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Biotechnology Advances
Verified
Journal Article
Open access
LBLuisa Bortesi
Luisa Bortesi
RFRainer Fischer
Rainer Fischer
Targeted genome editing using artificial nucleases has the potential to accelerate basic research as well as plant breeding by providing the means to modify genomes rapidly in a precise and predictable manner. Here we describe the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) system, a recently developed tool for the introduction of site-specific double-stranded DNA breaks. We highlight the strengths and weaknesses of this technology compared with two well-established genome editing platforms: zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs). We summarize recent results obtained in plants using CRISPR/Cas9 technology, discuss possible applications in plant breeding and consider potential future developments.

1 January 2017 in Biotechnology Advances
Verified
Journal Article
Open access
JZJulia Zischewski
Julia Zischewski
RFRainer Fischer
Rainer Fischer
LBLuisa Bortesi
Luisa Bortesi
The development of customizable sequence-specific nucleases such as TALENs, ZFNs and the powerful CRISPR/Cas9 system has revolutionized the field of genome editing. The CRISPR/Cas9 system is particularly versatile and has been applied in numerous species representing all branches of life. Regardless of the target organism, all researchers using sequence-specific nucleases face similar challenges: confirmation of the desired on-target mutation and the detection of off-target events. Here, we evaluate the most widely-used methods for the detection of on-target and off-target mutations in terms of workflow, sensitivity, strengths and weaknesses.

3 July 2018 in Plant Biotechnology Journal
Verified
Journal Article
Open access
PDF file
JJJulia Jansing
Julia Jansing
MSMarkus Sack
Markus Sack
SASruthy Maria Augustine
Sruthy Maria Augustine
RFRainer Fischer
Rainer Fischer
LBLuisa Bortesi
Luisa Bortesi
Summary: Plants offer fast, flexible and easily scalable alternative platforms for the production of pharmaceutical proteins, but differences between plant and mammalian N‐linked glycans, including the presence of β‐1,2‐xylose and core α‐1,3‐fucose residues in plants, can affect the activity, potency and immunogenicity of plant‐derived proteins. Nicotiana benthamiana is widely used for the transient expression of recombinant proteins so it is desirable to modify the endogenous N‐glycosylation machinery to allow the synthesis of complex N‐glycans lacking β‐1,2‐xylose and core α‐1,3‐fucose. Here, we used multiplex CRISPR/Cas9 genome editing to generate N. benthamiana production lines deficient in plant‐specific α‐1,3‐fucosyltransferase and β‐1,2‐xylosyltransferase activity, reflecting the mutation of six different genes. We confirmed the functional gene knockouts by Sanger sequencing and mass spectrometry‐based N‐glycan analysis of endogenous proteins and the recombinant monoclonal antibody 2G12. Furthermore, we compared the CD64‐binding affinity of 2G12 glycovariants produced in wild‐type N. benthamiana, the newly generated FX‐KO line, and Chinese hamster ovary (CHO) cells, confirming that the glyco‐engineered antibody performed as well as its CHO‐produced counterpart.

18 February 2010 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MPMarianna Polesani
Marianna Polesani
LBLuisa Bortesi
Luisa Bortesi
AFAlberto Ferrarini
Alberto Ferrarini
Anita ZamboniAnita Zamboni
Anita Zamboni
MFMarianna Fasoli
Marianna Fasoli
APAnnalisa Polverari
Annalisa Polverari
Background: Downy mildew is a destructive grapevine disease caused byPlasmopara viticola(Berk. and Curt.) Berl. and de Toni, which can only be controlled by intensive fungicide treatments. Natural sources of resistance from wild grapevine (Vitis) species are used in conventional breeding approaches, but the signals and effectors involved in resistance in this important crop species are not well understood.Results: Early transcriptional changes associated withP. viticolainfection in susceptibleV. viniferaand resistantV. ripariaplants were analyzed using the Combimatrix microarray platform. Transcript levels were measured 12 and 24 h post-inoculation, reflecting the time points immediately preceding the onset of resistance inV. riparia, as determined by microscopic analysis. Our data indicate that resistance inV. ripariais induced after infection, and is not based on differences in basal gene expression between the two species. The strong and rapid transcriptional reprogramming involves the induction of pathogenesis-related proteins and enzymes required for the synthesis of phenylpropanoid-derived compounds, many of which are also induced, albeit to a lesser extent, inV. vinifera. More interestingly, resistance inV. ripariaalso involves the specific modulation of numerous transcripts encoding components of signal transduction cascades, hypersensitive reaction markers and genes involved in jasmonate biosynthesis. The limited transcriptional modulation inV. viniferarepresents a weak attempted defense response rather than the activation of compatibility-specific pathways.Conclusions: Several candidate resistance genes were identified that could be exploited in future biotechnological approaches to increase disease resistance in susceptible grapevine species. Measurements of jasmonic acid and methyl jasmonate in infected leaves suggest that this hormone may also be involved inV. ripariaresistance toP. viticola.

10 September 2016 in Plant Biotechnology Journal
Verified
Journal Article
Open access
PDF file
LBLuisa Bortesi
Luisa Bortesi
XJXin Jin
Xin Jin
JZJulia Zischewski
Julia Zischewski
LPLucia Perez
Lucia Perez
LBLudovic Bassié
Ludovic Bassié
SSStefan Schillberg
Stefan Schillberg
Summary: The CRISPR/Cas9 system and related RNA‐guided endonucleases can introduce double‐strand breaks (DSBs) at specific sites in the genome, allowing the generation of targeted mutations in one or more genes as well as more complex genomic rearrangements. Modifications of the canonical CRISPR/Cas9 system from Streptococcus pyogenes and the introduction of related systems from other bacteria have increased the diversity of genomic sites that can be targeted, providing greater control over the resolution of DSBs, the targeting efficiency (frequency of on‐target mutations), the targeting accuracy (likelihood of off‐target mutations) and the type of mutations that are induced. Although much is now known about the principles of CRISPR/Cas9 genome editing, the likelihood of different outcomes is species‐dependent and there have been few comparative studies looking at the basis of such diversity. Here we critically analyse the activity of CRISPR/Cas9 and related systems in different plant species and compare the outcomes in animals and microbes to draw broad conclusions about the design principles required for effective genome editing in different organisms. These principles will be important for the commercial development of crops, farm animals, animal disease models and novel microbial strains using CRISPR/Cas9 and other genome‐editing tools.

1 August 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
CSChristian Schmitz
Christian Schmitz
LALilian González Auza
Lilian González Auza
DKDavid Koberidze
David Koberidze
SRStefan Rasche
Stefan Rasche
RFRainer Fischer
Rainer Fischer
LBLuisa Bortesi
Luisa Bortesi
Chitin is an abundant polysaccharide primarily produced as an industrial waste stream during the processing of crustaceans. Despite the limited applications of chitin, there is interest from the medical, agrochemical, food and cosmetic industries because it can be converted into chitosan and partially acetylated chitosan oligomers (COS). These molecules have various useful properties, including antimicrobial and anti-inflammatory activities. The chemical production of COS is environmentally hazardous and it is difficult to control the degree of polymerization and acetylation. These issues can be addressed by using specific enzymes, particularly chitinases, chitosanases and chitin deacetylases, which yield better-defined chitosan and COS mixtures. In this review, we summarize recent chemical and enzymatic approaches for the production of chitosan and COS. We also discuss a design-of-experiments approach for process optimization that could help to enhance enzymatic processes in terms of product yield and product characteristics. This may allow the production of novel COS structures with unique functional properties to further expand the applications of these diverse bioactive molecules.